RT @ACIR_org: Spotlight: (Original article appears in SpringerLink https://t.co/xBC1EkiGka) @Immunicum #clinicaltrial #Tcell #vaccine https…
RT @ACIR_org: Spotlight: (Original article appears in SpringerLink https://t.co/xBC1EkiGka) @Immunicum #clinicaltrial #Tcell #vaccine https…
RT @ACIR_org: Spotlight: (Original article appears in SpringerLink https://t.co/xBC1EkiGka) @Immunicum #clinicaltrial #Tcell #vaccine https…
Spotlight: (Original article appears in SpringerLink https://t.co/xBC1EkiGka) @Immunicum #clinicaltrial #Tcell #vaccine https://t.co/NRzUTUke2H
RT @AAPSComms: OPEN ACCESS Expert Review: "Ilixadencel – an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration"…
OPEN ACCESS Expert Review: "Ilixadencel – an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration" #PHARMRES https://t.co/LAuVHtjtOk https://t.co/LRuzuJGpce
@LIFse @BCF_1982 Finns smidigare sätt för solida tumörer än car-t. Immunicums Ilixadencel blir skräddarsytt i patientens tumör. https://t.co/fk2sy4BseH
Ilixadencel - an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration. https://t.co/qurQ99RzgK
RT @NK_papers: Ilixadencel - an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration. by Karlsson-Parra A, Kovac…
Ilixadencel - an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration. https://t.co/uDVbL6qzsG
Ilixadencel - an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration. by Karlsson-Parra A, Kovacka J, Heimann E, Jorvid M, Zeilemaker S, Longhurst S, Suenaert P https://t.co/Ds9FBHnPSm